Abmaxis, Inc. is a privately held biopharmaceutical company located in Santa Clara, California. It is dedicated to the discovery, optimization and development of monoclonal antibody (MAb) products for human therapeutics and diagnostics. The company has a seasoned management team with experience in the biotech, pharmaceutical and life science industries. Abmaxis has developed and validated a breakthrough antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM), which is used for building an internal product pipeline and for collaborations with global biotech and pharmaceutical partners. The product strategy is to develop a pipeline of products with a spectrum of risk profiles, ranging from next-generation of clinically proven antibody drugs with significantly improved attributes to antibodies against novel targets. Abmaxis collaborates with corporate partners who have proprietary targets or antibodies that require humanization and engineering.
| Website | http://www.abmaxis.org |
| Revenue | $13.2 million |
| Employees | View employees |
| Address | 3303 Octavius Dr Ste 103, Santa Clara, California 95054, US |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Pfizer, Amgen, The Janssen Pharmaceutical Companies of Johnson & Johnson, Novartis, Gilead Sciences, Genentech, Biogen, Regeneron, Scripps Research, Merck AH +39 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 3254 Companies |
Looking for a particular Abmaxis employee's phone or email?
Abmaxis Questions
The Abmaxis annual revenue was $13.2 million in 2026.
Abmaxis is based in Santa Clara, California.
The NAICS codes for Abmaxis are [325, 32, 541, 54, 3254].
The SIC codes for Abmaxis are [80, 283, 28].
